AUROBINDO PHARMA
Back to Cashflow Statement
|
AUROBINDO PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹120 Cr | ₹800 Cr | ₹1,814 Cr | ₹-2,969 Cr | ₹-1,365 Cr |
What is the latest Cash Flow from Financing Activities ratio of AUROBINDO PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹120 Cr |
| Mar2024 | ₹800 Cr |
| Mar2023 | ₹1,814 Cr |
| Mar2022 | ₹-2,969 Cr |
| Mar2021 | ₹-1,365 Cr |
How is Cash Flow from Financing Activities of AUROBINDO PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹120 Cr | -85.04 | |
| Mar2024 | ₹800 Cr | -55.89 | |
| Mar2023 | ₹1,814 Cr | Positive | |
| Mar2022 | ₹-2,969 Cr | Negative | |
| Mar2021 | ₹-1,365 Cr | - | |
Compare Cash Flow from Financing Activities of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹65,813.4 Cr | -2.9% | -6.9% | -4.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -2.9% |
-6.9% |
-4.8% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses